Category Archives: Human Longevity

The original Avengers kill thousands of characters in the MCU, but only one hero can claim the title of deadliest Avenger (and its not even close).

Marvel villains are notorious for racking up the on-screen body count, but even heroes like the Avengers have killed characters in the MCU. One-on-one showdowns between hero and villain are fertile ground for death and destruction, and when the Avengers assemble to collectively combat large-scale threats to the universe, the number of causalities in the good-guy corner really begins to add up. All matter of alien and human life from the mindless Outriders to cunning Hydra agents have met their maker at the hands of Nick Furys MCUheroes, but only one can claim the title of deadliest Avenger.

While new heroes and heroines join the ranks of the Avengers every year, the original six members of Nick Furys elite teamHulk, Iron Man, Black Widow, Captain America, Hawkeye, Thor remain the heart and soul upon which the franchise is built. And as the longest-tenured members of the MCU, with many boasting multiple solo moviesin addition to the four Avengerstitles, thePhase One heroes have shared in the unfortunate circumstance of engaging in the highest number of battles, thus vanquishing the highest number of foes. Any acts of violence the Avengers may have committed in the comics hold no bearing in determining their kill totals, and only direct kills are considered, regardless of any deaths, whether through negligence or collateral damage, that could be pinned on an Avenger as a result of a large-scale catastrophe like Sokovia. Similarly, the Avengers: Age of Ultronrobots do not count as kills.

Related: Every Character Hulk Has Fought In The MCU (& Who Won)

Greater superpowers and a longer life equate to a higher killing capacity. Enter Thor, arguably the most powerful of the original Avengers, and certainly the eldest. In Avengers: Infinity War, Thor states, Im fifteen hundred years old. Ive killed twice as many enemies as that, which would place the God of Thunder's kill count at a minimum of 3000. Thor battles entire armies of giants, elves, and more throughout the Avengers series, even in solo movies typically reserved for more intimate stories favoring character development over action. Thors 3000+ kills are more than any other Avenger in the MCU. However, remove Thors longevityfrom the equation, and the Asgardian draws much closer to the pack, possibly even losing his deadliest Avenger title to a hero from Earth.

For a mere human with no special powers, other than a genius intellect and billions of dollars, Tony Stark is a highly prolific killer. With a history in weapons technology and Iron Man'shighly advanced iron suitpacking a whole lot of firepower, Stark tallies enough kills to place him second on the list of deadliest Avenger. Hehits the ground running in his debut movie, Iron Man, killing dozens immediately after forging his first suit. Starks snap in Avengers: Endgamenot only vanquishes Thanos (and sadly, himself) but presumably hundreds of Thanos soldiers both on the ground and in the air.

Thor and Iron Man are in a league of their own, with the remaining four Avengers far behind. Cap's service in the deadliest conflict in human history during Captain America: The First Avengercertainly means he has a higher kill count than might be initially expected, but this no doubt pales to the Hulk - especially counting the green giant's time in Sakaar. Hawkeye and Black Widow round out the list at number five and six, respectively, as while Black Widows troubled history and Hawkeyes Ronin escapades could account for many deaths, their assassin roles were better suited to taking out individual targets, which means the volume of them is arguably far less.

Despite their reputation as the squeaky clean good guys, Marvels Avengers have killed thousands of characters in the MCU ranging from alien species to Hydra agents. Thor accounts for the lions share of kills, making him the deadliest Avenger, with Iron Man second and the others a good distance behind. However, those killed by the Avengers are a mere fraction of the lives lost at the hands of villains seeking to abolish freedom and subjugate the universe (or in Thanos mind, save it). In the words of Captain America, The price of freedom is high. It always has been. And its a price Im willing to pay.

More: MCU Theory: Winter Soldier Leads A New Superhero Team In Phase 4

Marvel Theory: X-Men Movies Are Part Of The MCU Multiverse

Nathan Miranda is a writer and artist with a B.A. degree in Media Arts & Culture from Occidental College in Los Angeles, CA. Prior to writing for Screen Rant, Nathan worked for Regal Cinemas where he helped build and managed their blog, Regal Reel, to which he also regularly contributed. Nathan teamed with his brother Joseph to publish two children's books in their World Adventure Series, an educational fiction series featuring characters of different nationalities from around the world. The first two books are available at Amazon in print and ebook.As an artist, Nathan specializes in colored pencils. His artwork focuses primarily on film and sports. You can view his portfolio on bonusroomart.comFollow Nathan on Instagram @bonusroomart or on Twitter @NathanMiranda52

Read this article:
Which Avenger Has Killed The Most Characters In The MCU - Screen Rant

Nearly 2,000 years ago in an obscure village, a child was born of a peasant woman. He was born in a supernatural way conceived by the Holy Spirit, and born of a virgin. He came from the throne of his father to the womb of a woman. He was born in the very poorest of circumstances, but the air above was filled with the hallelujahs of a heavenly host. His lodging was a stable, but a star drew distinguished visitors from afar.

His birth was contrary to the laws of life. His death was contrary to the laws of death. No miracle is so inexplicable as his life and his teaching. He put on humanity that we might put on divinity. He became the son of man that we might become sons and daughters of God.

He lived in poverty and was reared in obscurity. He was rich, yet for our sakes he became poor. He slept in anothers manger. He cruised the lake in another mans boat. He rode on a borrowed beast. He was buried in a rich mans tomb.

He never traveled extensively. Only once did he cross the borders of the land; and that was during his childhood exile. He never put his foot inside a big city, nor traveled even 200 miles from his birthplace. He grew up in another village where he worked as a carpenter until he was 30. Then for 3 years he served as an itinerant preacher.

He never held a public office. He never had a family or owned a home. In infancy, he startled a king. In boyhood, he puzzled the doctors. Even at 12 years of age, he proved he was far in advance of the theologians. This man never had a formal education. He never went to college or seminary, yet the profoundest wisdom of men has never equaled His Sermon on the Mount and his last discourses in the Gospel of John, Chapters 13 through 17.

Jesus painted no pictures; yet, some of the finest works of art received their inspiration from him. Jesus wrote no poetry; but scores of the worlds greatest poets were inspired by him. He never wrote a book, yet all the libraries in the world could not even begin to hold all of the books that have been written about him. He never wrote a song, yet he furnished the theme of more songs than all the songwriters combined. He never founded a college.

In manhood, he ruled the elements. He walked on the waters and they supported him. He calmed the raging sea. Even demons obeyed him! He fed the hungry multitude with just a little boys lunch.

He healed the multitudes without medicine, and made no charge for his services. He never practiced psychiatry, yet he has healed more broken hearts than all doctors. He broke up funerals and gave back the life of those who were dead.

While he was still young, the tide of public opinion turned against him. He came to his own people and they rejected him. He was turned over to his enemies and went through the mockery of a trial. Even though he was innocent, he was sentenced to death on a cross between two thieves. His captors took turns lashing his back with a whip. They knelt before him in mock homage and then arose to spit in his face.

While he was dying, his executioners gambled for the only piece of property he had on Earth: the simple robe he had worn. His crucifixion was the crime of all crimes, but on Gods side, only his infinite suffering could have made possible our redemption. When he died, few men mourned; but a black crepe was hung over the sun. Men trembled, though not for their sins; and the Earth beneath shook under the load. His dying words were: Father, forgive them. They dont know what they are doing.

By his suffering and death on the cross, he paid completely for the sins of all who believe in him. He was pierced for our transgressions, He was crushed for our iniquities; the punishment that brought us peace was upon Him, and by His wounds we are healed.

He was bruised and brought healing. He was pierced and eased pain. He was persecuted and brought freedom. He was dead and brought life. He has risen and brings power. He reigns and brings peace.

But three days later this man arose from the dead living proof that he was, as he had claimed, the savior whom God had sent, the incarnate Son of God.

After showing himself alive to his disciples, he ascended into heaven. He is now seated at the right hand of God and intercedes in our behalf. He will soon come again in the clouds of heaven with power and great glory for his own born-again, blood-bought followers to be forever with him. Then he will judge the world in righteousness, when every knee shall bow to him, and every tongue shall confess that he is Lord to the glory of the almighty God.

He preached his Gospel for only 3 years, and yet this mans life has changed the course of human history. This man is the perpetual theme of all preaching, the pivot point around which the events of the ages revolve, the only one capable of providing salvation of the human race.

Nineteen hundred years have come and gone, yet he still lives. His birth divides the history of mankind into two eras B.C. and A.D. One day of every week is set aside in remembrance of him. Christmas and Easter celebrate his birth and resurrection.

He is light, love, longevity, and he is Lord. He is gentleness, goodness, grace, and he is God. He is holy, righteous, mighty, powerful and pure. His ways are right. His word is true. His will is unchanging.

He is the ever perfect one the chief among 10,000, the only one who can satisfy the soul and give everlasting life to those who choose to believe in him. Jesus is altogether lovely. He is my savior and my God. He is my Lord and he rules my life. He is my joy, and he is my comfort.

I serve him because his bond is love, his burden is light and his goal for me is abundant life. I follow him because he is the wisdom of the wise, power for those who are weak, the ancient of days, the leaders of leaders, and he is coming again.

His goal is a personal relationship with me. He will never leave me, never forsake me, never mislead me, never forget me, never overlook me, and never cancel my appointment in his appointment book.

When I fall, he lifts me up. When I fail, he forgives. When I am weak, he is strong. When I am lost, he is the way. When I am afraid, he is my courage. When I stumble, he steadies me. When I am hurt, he heals me. When I am broken, he mends me. When I am hungry, he feeds me. When I face trials, he is my defense attorney. When I face persecution, he is my shield. When my heart is troubled, he comforts me. When I face loss, he fills the emptiness in my life. When I face death, he will carry me home.

He is God, and he is faithful. I am his, and he is mine.

Jesus was born, so that I could be born again. He became poor, that I might possess great wealth.

He became homeless, that I might have a mansion.

He was forsaken, that I would always have friends.

He was bound, that I might have perfect liberty.

He was sad, that I might have real joy. He descended, that I should be lifted up.

He became a servant, that I might be a son forever.

He was made sin, that I should share his righteousness. He died, that I should never taste eternal death.

If you are wondering why I can feel so secure, understand this: God said it, I believe it, and that settles it. God is in control. And that means that it is well with my soul all because of this one solitary life.

Don Kastens is pastor of Louisville Christian Church. His writing is based on the poem One Solitary Life by David Schrock.

More:
Son of peasant woman comes to save the world - Maryville Daily Times

PLYMOUTH MEETING, PA [December 3, 2020] The National Comprehensive Cancer Network (NCCN) Oncology Research Program (ORP) today announced five projects selected to receive funding for clinical and preclinical evaluation of abemaciclib. Abemaciclib is a cyclin dependent kinase (CDK) 4 & 6 inhibitor used in the treatment of hormone receptor-positive (HR+), human epidermal growth factor receptor 2-negative (HER2-) breast cancer. The proposals were reviewed and awarded by a scientific steering committee made up of experts from NCCN Member Institutions, and the NCCN ORP is handling project oversight. Research funding is being provided by a grant from Eli Lilly and Company.

The selected projects are:

Congratulations to all of these accomplished grantees, said Wui-Jin Koh, MD, Chief Medical Officer, NCCN. We are eager to learn more about which patients develop resistance to CDK 4 & 6 inhibitors, the potential underlying mechanisms, and ways in which such resistance can be overcome, in order to improve the application of this potentially life-prolonging therapy. This research is one of the many ways we work to improve longevity and quality-of-life for people with metastatic breast cancer.

I have had a frontline view of how metastatic breast cancer can be unpredictable and complex, said Maura Dickler, MD, Vice President, Late Phase Development, Lilly Oncology. Every day the lives ofan estimated 115 women and menin the United States are lost as a result of this disease. Lilly is honored to support this research because it is critical in furthering our efforts to improve treatment options for people living with metastatic breast cancer.

The NCCN ORP fosters innovation and knowledge discovery that improves the lives of people with cancer and supports preclinical, translational, clinical research and quality improvement projects in oncology at NCCN Member Institutions. In an effort to improve collaboration in cancer research, the NCCN ORP also maintains a shared resources website and an informed consent database. For more information, visit NCCN.org/orp.

* The preclinical studies by Drs. Olmez and Zeng have already begun. The remainder are expected to commence in mid-2021.

# # #

About the National Comprehensive Cancer Network

The National Comprehensive Cancer Network (NCCN) is a not-for-profit alliance of leading cancer centers devoted to patient care, research, and education. NCCN is dedicated to improving and facilitating quality, effective, efficient, and accessible cancer care so patients can live better lives. The NCCN Clinical Practice Guidelines in Oncology (NCCN Guidelines) provide transparent, evidence-based, expert consensus recommendations for cancer treatment, prevention, and supportive services; they are the recognized standard for clinical direction and policy in cancer management and the most thorough and frequently-updated clinical practice guidelines available in any area of medicine. The NCCN Guidelines for Patients provide expert cancer treatment information to inform and empower patients and caregivers, through support from the NCCN Foundation. NCCN also advances continuing education, global initiatives, policy, and research collaboration and publication in oncology. Visit NCCN.org for more information and follow NCCN on Facebook @NCCNorg, Instagram @NCCNorg, and Twitter @NCCN.

Follow this link:
Grantees Awarded as Part of the Breast Cancer Research Project Between NCCN and Lilly Oncology - Newswise

Investment opportunities posted on this website are "private placements" of securities that are not publicly traded, are subject to holding period requirements, and are intended for investors who do not need a liquid investment. Investing in private companies may be considered highly speculative and involves a high degree of risk, including the risk of substantial loss of investment. Investors must be able to afford the loss of their entire investment. See our Risk Factors for a more detailed explanation of the risks involved by investing through EquityZens platform.

EquityZen Securities LLC (EquityZen Securities) is a subsidiary of EquityZen Inc. EquityZen Securities is a broker/dealer registered with the Securities Exchange Commission and is a FINRA/SIPC member firm.

Equity securities are offered through EquityZen Securities. Check the background of this firm on FINRAs BrokerCheck.

EquityZen.com is a website operated by EquityZen Inc. ("EquityZen"). By accessing this site and any pages thereof, you agree to be bound by our Terms of Use.EquityZen and logo are trademarks of EquityZen Inc. Other trademarks are property of their respective owners. 2020 EquityZen Inc. All rights reserved.

Visit link:
Buy or sell Human Longevity stock pre IPO via an EquityZen ...

HONG KONG, Nov. 26, 2020 /PRNewswire/ -- Regent Pacific Group Limited ("Regent Pacific" or the "Company" and together with its subsidiaries, the "Group"; SEHK:0575.HK)'s Deep Longevity, Inc, a company subject to a conditional acquisition by the Group which is a pioneer in deep biomarkers of aging and longevity today announced a collaboration with My Care Express Merrillville to deploy an extensive range of AI-powered aging clocks. Deep Longevity is to develop and provide the customized predictors of human biological age to the network of My Care Express clinicians and to provide a training program in longevity medicine.

Deep Longevityaging clocks are supported by a number of academic publications summarized in a recent review titled "BioHorology and biomarkers of aging: Current state-of-the-art, challenges and opportunities"

My Care Express Merrillville has been a provider of preventative and total health care to its patients since it opened. My Care Express has a unique approach to wellness and longevity by helping patients establish wellness goals to live happier, healthier and longer lives. Deep Longevity and My Care Express will partner to see the impact that the utilization of aging clocks has on their patients. "We have always believed that the more information our patients have regarding their health, the better choices they will make. We believe that implementing aging clocks will give our patients a better understanding of their current health and help them achieve their wellness goals", said Dr. Faiz Shareef.

In the scope of the partnership My Care Express physicians will be trained in deep aging clocks and will be able to provide their customers with AgeMetric reports and engage in advanced research to assess the performance of aging clocks in the context of their wellness journey.

"The traditional approach to preventative medicine is focused on preventing disease by diagnosing the symptoms early or reducing the risks of disease. The AI-guided longevity medicine goes much further than that and is focusing on tracking the person's rates of aging at many levels, identification of longevity bottlenecks, and utilizing the latest advances in science and technology to slow down or reverse biological and psychological aging. We are very happy to have My Care Express join the rapidly growing network of our research and clinical partners focused on providing customers with extra years of productive and happy life", said Alex Zhavoronkov, Chief Longevity Officer of Deep Longevity Inc.

About Deep Longevity

Deep Longevity is subject to a conditional acquisition by Regent Pacific Group Limited (SEHK:0575.HK), a public company whose securities are listed on The Stock Exchange of Hong Kong Limited. Deep Longevity is developing explainable artificial intelligence systems to track the rate of aging at the molecular, cellular, tissue, organ, system, physiological, and psychological levels. It is also developing systems for the emerging field of longevity medicine enabling physicians to make better decisions on the interventions that may slow down, or reverse the aging processes. Deep Longevity developed Longevity as a Service (LaaS) solution to integrate multiple deep biomarkers of aging dubbed "deep aging clocks" to provide a universal multifactorial measure of human biological age. Originally incubated by Insilico Medicine, Deep Longevity started its independent journey in 2020 after securing a round of funding from the most credible venture capitalists specializing in biotechnology, longevity, and artificial intelligence. ETP Ventures, Human Longevity and Performance Impact Venture Fund, BOLD Capital Partners, Longevity Vision Fund, LongeVC, co-founder of Oculus, Michael Antonov, and other experts AI and biotechnology investors supported the company. Deep Longevity established a research partnership with one of the most prominent longevity organizations, Human Longevity, Inc. to provide a range of aging clocks to the network of advanced physicians and researchers.

http://longevity.ai/

About Regent Pacific (SEHK: 0575.HK)

Regent Pacific is a diversified investment group based in Hong Kong currently holding various corporate and strategic investments focusing on the healthcare, wellness, and life sciences sectors. The Group has a strong track record of investments and has returned approximately US$298 million to shareholders in the 21 years of financial reporting since its initial public offering.

http://www.regentpac.com/

About My Care Express Merrillville

My Care Express Merrillville is a clinic in Northwest Indiana that provides primary and urgent care with a focus on preventative medicine. My Care Express believes in a proactive approach to healthcare by providing its patients with tools that will help them live longer healthier lives. Located on the border of Indiana and Illinois, My Care Express has a dynamic and diverse practice. For more information visit mycareexpressclinic.com

SOURCE Regent Pacific Group Limited

http://www.regentpac.com

Here is the original post:
Deep Longevity Adds Partnership with My Care Express in Merrillville To Add Biomarkers of Aging and Longevity - PRNewswire

GOOD nutrition, clean environments, accessibility to good healthcare and healthy lifestyles have increased human longevity. Nevertheless, the quest of increasing longevity is insatiable. As medical science pushes the boundaries of human lifespan, delving into the science of longevity can help us sieve through the reams of information and distil the essence of anti-ageing and cell preservation.

Cellular ageing

Cell ageing or cellular senescence is a physiological state with permanent cessation of the ability of the cell to replicate and accumulation of damaged DNA ( basic building blocks of genes), and this process is increased by ageing. This cellular senescence is marked by shortening of the protective terminal ends of the chromosomes which are called telomeres.

Telomeres are like plastic caps at the ends of shoelaces, preventing them from being frayed and damaged. Shortening of the telomere is a sign of cellular senescence.

In 1979, the first of the SIR (silent information regulator) proteins or sirtuins was reported. Over time more members of this protein group were found. In 1999, the publication of a study that reported that increased sirtuin activity could increase the lifespan of yeast cells by 70 per cent heralded a major breakthrough that accelerated the interest and research in sirtuins.

Stay updated with BT newsletters

Since then, there has been a growing body of evidence that the cell has a group of anti-ageing proteins, the sirtuins, that are essential for delaying cellular senescence and increasing the lifespan of organisms.

Anti-ageing proteins

Core to the science of anti-ageing is this group of proteins called sirtuins. In human cells, there are seven sirtuins (SIRT 1 to 7) with various roles within the cell. Three of these sirtuins (SIRT 3,4,5) control the generation of power for the needs of the cells and function in the mitochondria (power generator which produce the energy for the needs of the cell) with roles in cellular antioxidant balance and lipid metabolism.

Another three sirtuins (SIRT 1, 6, 7) control the genetic framework in the cell and function in the cell nucleus (the central core of the genetic material in the cell) with roles in gene expression and DNA repair. There is one sirtuin (SIRT 2 mainly) which control the environmental processes within the cell and function in the cytoplasm (the liquid content within the cell).

As an analogy, if the cell is a factory, the sirtuins are the executive management of the company directing and controlling all the aspects of the cell's activities. They play important roles in maintaining the integrity of the cellular genetic structure, keeping the genetic material (chromatin) in a "wound up" protected state to reduce damage and in repairing damaged DNA.

Mechanisms of action

The main mechanisms of suppression of cellular senescence by sirtuin activity is via the actions of preventing telomere shortening or attrition, and promoting the repair of damaged DNA.

Many proteins in the cells have a chemical tag called an acetyl group attached to it. One of the key ways in which sirtuins work is by the removal of the acetyl group from other molecules or proteins, thereby affecting the activity of the protein. This action has significant impact on the control centre of the cell, namely the activity of the genetic material or chromatin.

The basic building block of the genetic material, the DNA, is wrapped around groups of proteins called histones allowing the genetic material (chromatin) to be packed more compactly.

When the histone protein has the acetyl group chemical tag , it causes the chromatin to be partially unwound and hence exposing the unwound DNA to be copied, thereby allowing the gene instruction to be passed to another cell or protein. As an analogy, it is as if a door to the office is opened and people are allowed to go into the office to copy instructions which are then passed to other offices.

Once all the instructions are copied, the office door is closed. Hence, once the task is completed, the chromatin will not remain unwound as it will be more vulnerable to damage if it remains open.

Subsequently, the sirtuins can then remove the acetyl group from the histones which will then allow the chromatin to be closed by being "wound up" tightly, preventing DNA material from being copied and in effect silence the gene.

Besides histones, sirtuins target other non-histone proteins such as proteins involved in copying genetic information and proteins that are involved in the repair of DNA. They are also known to regulate the production of the enzyme telomerase which is required for telomere elongation and maintenance of the integrity of the telomere.

Most human cells have insufficient telomerase and hence there is progressive shortening of the telomere which is strongly indicative of progressive cellular ageing. Elongation of the chromosomal telomere is tantamount to reversing the biological clock.

Beneficial effects of sirtuin activity

Studies have shown that sirtuins have roles in the regulation of copying of gene information, modulation of energy production, prolongation of cell survival, reduction of DNA damage, reduction of cell damage and prolongation of longevity. Increased sirtuin activity in mammals has been associated with a delayed onset of age-related diseases and an increase in longevity.

Sirtuins appear to be able to inhibit axonal (nerve fibre) degeneration, a process that often precedes the death of nerve cells as seen in neurodegenerative diseases such as Parkinson's and Alzheimer's disease.

It may also have protective effect on nerve cells, reducing processes that lead to the death o f nerve cells and the development of Alzheimer's disease.

Loss of sirtuin activity has been implicated in the development of cardiovascular and metabolic diseases including degeneration of arteries, acute damage to the heart muscle, thickening of the heart muscle, abnormal heart rhythms, high blood pressure, obesity, diabetes mellitus and abnormal lipid levels. While most of the studies have been done in animals, there is an increasing number of human studies.

There is presently an increasing body of evidence that shows increased sirtuin activity is indispensable for delaying cellular senescence and appears to protect the body against many age related diseases. In addition, studies support the role of sirtuins as anti-aging agents and potentially prolong longevity.

Hence, lifestyle, dietary and pharmacological choices that increase sirtuin activity can potentially increase the anti-ageing effects and prolong longevity. These will be discussed in the next article where we will examine how we can make better decisions to increase our quality of life and lifespan.

Visit link:
Unravelling the holy grail of anti-ageing and longevity - The Business Times

The recent report on the Longevity and Anti-senescence Therapy market predicts the industrys performance for the upcoming years to help stakeholders in making the right decisions that can potentially garner strong returns. Further, the document provides comprehensive analysis of the key industry trends as well as the opportunities that will ensure an upward growth trajectory in the coming years. It also focuses on developing strategies for challenges faced by the industry. Moreover, an exhaustive discussion of the latest updates including the impact of COVID-19 pandemic is furnished in the study.

Key highlights from COVID-19 impact analysis:

An overview of the regional landscape:

Request Sample Copy of this Report @ https://www.express-journal.com/request-sample/268954

Other important takeaways from the Longevity and Anti-senescence Therapy market report:

Key aspects listed in the report:

Points Covered in The Report:

The points that are discussed within the report are the major market players that are involved in the market such as manufacturers, raw material suppliers, equipment suppliers, end users, traders, distributors, etc.

The complete profile of the companies is mentioned. And the capacity, production, price, revenue, cost, gross, gross margin, sales volume, sales revenue, consumption, growth rate, import, export, supply, future strategies, and the technological developments that they are making are also included within the report. The historical data and forecast data from 2020 to 2025.

The growth factors of the market are discussed in detail wherein the different end users of the market are explained in detail.

Data and information by manufacturer, by region, by type, by application, etc., and custom research can be added according to specific requirements. The report contains a SWOT analysis of the market. Finally, the report contains the conclusion part where the opinions of the industrial experts are included.

Recent Industry Trend:

The report contains the profiles of various prominent players in the Global Longevity and Anti-senescence Therapy Market. Different strategies implemented by these vendors have been analyzed and studied to gain a competitive edge, create unique product portfolios and increase their market share. The study also sheds light on major global industry vendors. Such essential vendors consist of both new and well-known players. Besides, the business report contains important data relating to the launch of new products on the market, specific licenses, domestic scenarios and the strategies of the organization implemented on the market.

MAJOR TOC OF THE REPORT:

Chapter 1 Industry Overview

Chapter 2 Production Market Analysis

Chapter 3 Sales Market Analysis

Chapter 4 Consumption Market Analysis

Chapter 5 Production, Sales and Consumption Market Comparison Analysis

Chapter 6 Major Manufacturers Production and Sales Market Comparison Analysis

Chapter 7 Major Product Analysis

Chapter 8 Major Application Analysis

Chapter 9 Industry Chain Analysis

Chapter 10 Global and Regional Market Forecast

Chapter 11 Major Manufacturers Analysis

Chapter 12 New Project Investment Feasibility Analysis

Chapter 13 Conclusions

Chapter 14 Appendix

Request Customization on This Report @ https://www.express-journal.com/request-for-customization/268954

Continued here:
Longevity and Anti-senescence Therapy Market size and Key Trends in terms of volume and value 2020-2025 - Express Journal

The Genomic Biomarker Market grew in 2019, as compared to 2018, according to our report, Genomic Biomarker Market is likely to have subdued growth in 2020 due to weak demand on account of reduced industry spending post Covid-19 outbreak. Further, Genomic Biomarker Market will begin picking up momentum gradually from 2021 onwards and grow at a healthy CAGR between 2021-2025

Deep analysis about market status (2016-2019), competition pattern, advantages and disadvantages of products, industry development trends (2019-2025), regional industrial layout characteristics and macroeconomic policies, industrial policy has also been included. From raw materials to downstream buyers of this industry have been analysed scientifically. This report will help you to establish comprehensive overview of the Genomic Biomarker Market

Get a Sample Copy of the Report at: https://i2iresearch.com/report/global-genomic-biomarker-market-2020-market-size-share-growth-trends-forecast-2025/#download-sample

The Genomic Biomarker Market is analysed based on product types, major applications and key players

Key product type:OncologyCardiologyNeurologyNephrology

Key applications:HospitalsDiagnostic and research laboratories

Key players or companies covered are:Bio-RadBeckman CoulterMyriad GeneticsThermo Fisher ScientificRocheQIAGENEpigenomicsAlmacPfizerHuman LongevityValiRxPersonalisEagle GenomicsEmpire GenomicsAgilentIllumina

The report provides analysis & data at a regional level (North America, Europe, Asia Pacific, Middle East & Africa , Rest of the world) & Country level (13 key countries The U.S, Canada, Germany, France, UK, Italy, China, Japan, India, Middle East, Africa, South America)

Inquire or share your questions, if any: https://i2iresearch.com/report/global-genomic-biomarker-market-2020-market-size-share-growth-trends-forecast-2025/

Key questions answered in the report:1. What is the current size of the Genomic Biomarker Market, at a global, regional & country level?2. How is the market segmented, who are the key end user segments?3. What are the key drivers, challenges & trends that is likely to impact businesses in the Genomic Biomarker Market?4. What is the likely market forecast & how will be Genomic Biomarker Market impacted?5. What is the competitive landscape, who are the key players?6. What are some of the recent M&A, PE / VC deals that have happened in the Genomic Biomarker Market?

The report also analysis the impact of COVID 19 based on a scenario-based modelling. This provides a clear view of how has COVID impacted the growth cycle & when is the likely recovery of the industry is expected to pre-covid levels.

Contact us:i2iResearch info to intelligenceLocational Office: *India, *United States, *GermanyEmail: [emailprotected]Toll-free: +1-800-419-8865 | Phone: +91 98801 53667

Visit link:
Genomic Biomarker Market Research Report 2020 with Business Overview and Manufacturers Profiles till 2026 - Cheshire Media

Roots Analysis has announced the addition of Microbiome Therapeutics Market, 2015-2030 report to their offering. The report provides a comprehensive study on the current landscape and the future outlook of the evolving pipeline of products in this area. While the field has garnered the interest of several companies, there are no approved microbiome drugs available in the market yet; Faecal Microbiota Transplant (FMT) is the only commercially available procedure till date. However, the development pipeline of microbiome therapeutics has several promising candidates that are likely to result in commercial success stories in the foreseen future.

Ishita Nanda, the principal analyst, said, Among other elements, the report also elaborates on new microbiome based diagnostic solutions being developed and the upcoming opportunities in this market for different stakeholders.One of the key objectives outlined for this report was to understand the future potential of the market. This was done by analyzing:

Nanda added, The study provides a detailed market forecast and opportunity analysis for the short-mid term (2015-2022) and long term (2022-2030). Our opinions and insights, presented in this study, were influenced by several discussions conducted with experts in this area. These included senior representatives at Assembly Biosciences, Da Volterra, Metabiomics, MicroBiome Therapeutics and Rebiotix.

The 218 page report includes detailed profiles and an assessment of the microbiome therapeutics programs of many companies including:

Details of some other firms developing microbiome related diagnostics and companion diagnostics have also been captured. Examples include (in alphabetical order) Admera Health, Biocartis, Enterome Bioscience, Human Longevity, Metabiomics, Microbiome Diagnostics, Viomer, Whole Biome.

For additional details, please visithttp://www.rootsanalysis.com/reports/view_document/microbiome-therapeutics-market-2015-2030/117.htmlor email[emailprotected]

About Roots Analysis

Roots Analysis is a specialist market research company, sharing fresh and independent perspectives in the bio-pharmaceutical industry. The in-depth research, analysis and insights are driven by an experienced leadership team which has gained many years of significant experience in this sector. If youd like us to help you with your growing business needs, get in touch at[emailprotected]

Here is the original post:
Microbiome Therapeutics Market: What's the Future Potential? Roots Analysis - Cheshire Media

Precision Medicine Software Marketis anticipated to discover Robust Growth by 2026. This report focuses on the leading key players with global perspective with a professional and in-depth study on the current state of Precision Medicine SoftwareIndustry. Precision Medicine Softwaremarket research report provides important market strategies and Latest trends with discussion of market consumption, major drivers, restraints and market share forecasted to 2026.

The Precision Medicine Software Market Report further describes detailed information about tactics and strategies used by leading key companies in the Precision Medicine Softwareindustry. It also gives an extensive study about different market segments and regions.

The Precision Medicine Softwaremarket report provides answers to the following key questions:

To get more information, Ask for Sample PDF:https://inforgrowth.com/sample-request/6461601/precision-medicine-software-market

The Precision Medicine SoftwareMarket report provides basic information about Precision Medicine Softwareindustry, definition, classification, application, industry chain structure, industry overview; international market analysis. This report studies sales (consumption) of Precision Medicine Softwaremarket, focuses on the top players, with sales, price, revenue and market share with volume and value for each region.

Top Key Players in Precision Medicine Softwaremarket: Syapse, , Allscripts, , Qiagen, , Roper Technologies, , Fabric Genomics, , Foundation Medicine, , Sophia Genetics, , PierianDx, , Human Longevity, , Translational Software, , Gene42, Inc, , Lifeomic Health

Precision Medicine SoftwareMarket on the basis of Product Type:Cloud-based, , On-premise

Precision Medicine SoftwareMarket on the basis of Applications:Healthcare Providers, , Pharmaceutical and Biotechnology Companies, , Research Centers and Government Institutes, , Others,

Get up to 30% instant discount Under Our Thanksgiving Discount OFFER;https://inforgrowth.com/discount/6461601/precision-medicine-software-market

Impact of COVID-19:

Precision Medicine SoftwareMarket report analyses the impact of Coronavirus (COVID-19) on the Precision Medicine Softwareindustry.Since the COVID-19 virus outbreak in December 2019, the disease has spread to almost 180+ countries around the globe with the World Health Organization declaring it a public health emergency. The global impacts of the coronavirus disease 2019 (COVID-19) are already starting to be felt, and will significantly affect the Precision Medicine Softwaremarket in 2020.

The outbreak of COVID-19 has brought effects on many aspects, like flight cancellations; travel bans and quarantines; restaurants closed; all indoor events restricted; emergency declared in many countries; massive slowing of the supply chain; stock market unpredictability; falling business assurance, growing panic among the population, and uncertainty about future.

COVID-19 can affect the global economy in 3 main ways: by directly affecting production and demand, by creating supply chain and market disturbance, and by its financial impact on firms and financial markets.

Get the Sample ToC and understand the COVID19 impact and be smart in redefining business strategies.https://inforgrowth.com/CovidImpact-Request/6461601/precision-medicine-software-market

Key Questions Answered in this Report:

What is the market size of the Precision Medicine Softwareindustry?This report covers the historical market size of the industry (2013-2019), and forecasts for 2020 and the next 5 years. Market size includes the total revenues of companies.

What is the outlook for the Precision Medicine Softwareindustry?This report has over a dozen market forecasts (2020 and the next 5 years) on the industry, including total sales, a number of companies, attractive investment opportunities, operating expenses, and others.

What industry analysis/data exists for the Precision Medicine Softwareindustry?This report covers key segments and sub-segments, key drivers, restraints, opportunities, and challenges in the market and how they are expected to impact the Precision Medicine Softwareindustry. Take a look at the table of contents below to see the scope of analysis and data on the industry.

How many companies are in the Precision Medicine Softwareindustry?This report analyzes the historical and forecasted number of companies, locations in the industry, and breaks them down by company size over time. Report also provides company rank against its competitors with respect to revenue, profit comparison, operational efficiency, cost competitiveness and market capitalization.

What are the financial metrics for the industry?This report covers many financial metrics for the industry including profitability, Market value- chain and key trends impacting every node with reference to companys growth, revenue, return on sales, etc.

What are the most important benchmarks for the Precision Medicine Softwareindustry?

Is there any query? Ask to our Industry Expert: https://inforgrowth.com/enquiry/6461601/precision-medicine-software-market

FOR ALL YOUR RESEARCH NEEDS, REACH OUT TO US AT:Address: 6400 Village Pkwy suite # 104, Dublin, CA 94568, USAContact Name: Rohan S.Email:[emailprotected]Phone: +1-909-329-2808UK: +44 (203) 743 1898

Read more from the original source:
Precision Medicine Software Market 2020: Potential growth, attractive valuation make it is a long-term investment | Know the COVID19 Impact | Top...